A detailed history of Avestar Capital, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Avestar Capital, LLC holds 10,980 shares of JNJ stock, worth $1.71 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
10,980
Previous 12,504 12.19%
Holding current value
$1.71 Million
Previous $1.98 Million 18.91%
% of portfolio
0.17%
Previous 0.21%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$144.38 - $157.78 $220,035 - $240,456
-1,524 Reduced 12.19%
10,980 $1.6 Million
Q1 2024

May 10, 2024

BUY
$155.22 - $162.74 $649,595 - $681,066
4,185 Added 50.31%
12,504 $1.98 Million
Q4 2023

Feb 12, 2024

BUY
$145.6 - $158.88 $178,360 - $194,628
1,225 Added 17.27%
8,319 $1.3 Million
Q3 2023

Oct 20, 2023

BUY
$155.75 - $174.48 $118,837 - $133,128
763 Added 12.05%
7,094 $1.1 Million
Q2 2023

Aug 01, 2023

SELL
$154.35 - $166.11 $630,365 - $678,393
-4,084 Reduced 39.21%
6,331 $1.05 Million
Q1 2023

Apr 20, 2023

SELL
$151.05 - $180.26 $296,209 - $353,489
-1,961 Reduced 15.85%
10,415 $1.61 Million
Q4 2022

Jan 20, 2023

BUY
$160.2 - $179.79 $226,843 - $254,582
1,416 Added 12.92%
12,376 $0
Q3 2022

Oct 26, 2022

BUY
$161.33 - $179.52 $179,882 - $200,164
1,115 Added 11.33%
10,960 $1.79 Million
Q2 2022

Jul 28, 2022

SELL
$168.19 - $186.01 $48,606 - $53,756
-289 Reduced 2.85%
9,845 $1.75 Million
Q1 2022

Apr 26, 2022

BUY
$158.14 - $179.59 $121,767 - $138,284
770 Added 8.22%
10,134 $1.8 Million
Q4 2021

Feb 01, 2022

SELL
$155.93 - $173.01 $99,951 - $110,899
-641 Reduced 6.41%
9,364 $1.6 Million
Q3 2021

Nov 09, 2021

SELL
$161.5 - $179.47 $23,256 - $25,843
-144 Reduced 1.42%
10,005 $1.62 Million
Q2 2021

Aug 03, 2021

BUY
$159.48 - $171.07 $216,254 - $231,970
1,356 Added 15.42%
10,149 $1.67 Million
Q1 2021

May 03, 2021

SELL
$153.07 - $170.48 $16,684 - $18,582
-109 Reduced 1.22%
8,793 $1.42 Million
Q4 2020

Feb 01, 2021

SELL
$137.11 - $157.38 $20,292 - $23,292
-148 Reduced 1.64%
8,902 $1.4 Million
Q3 2020

Oct 29, 2020

SELL
$140.38 - $153.83 $32,989 - $36,150
-235 Reduced 2.53%
9,050 $1.3 Million
Q2 2020

Jul 29, 2020

BUY
$128.81 - $155.51 $366,335 - $442,270
2,844 Added 44.15%
9,285 $1.31 Million
Q1 2020

May 12, 2020

SELL
$111.14 - $153.99 $114,696 - $158,917
-1,032 Reduced 13.81%
6,441 $845,000
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $6,885 - $7,907
54 Added 0.73%
7,473 $1.09 Million
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $110,827 - $124,088
873 Added 13.34%
7,419 $960,000
Q2 2019

Aug 06, 2019

BUY
$131.15 - $144.24 $2,491 - $2,740
19 Added 0.29%
6,546 $882,000
Q1 2019

May 09, 2019

SELL
$125.72 - $139.79 $4,023 - $4,473
-32 Reduced 0.49%
6,527 $883,000
Q4 2018

Jan 25, 2019

SELL
$122.84 - $147.84 $2,702 - $3,252
-22 Reduced 0.33%
6,559 $819,000
Q3 2018

Oct 23, 2018

BUY
$121.58 - $142.88 $22,249 - $26,147
183 Added 2.86%
6,581 $881,000
Q2 2018

Aug 10, 2018

BUY
$119.4 - $131.76 $14,566 - $16,074
122 Added 1.94%
6,398 $751,000
Q1 2018

May 10, 2018

BUY
$125.1 - $148.14 $19,140 - $22,665
153 Added 2.5%
6,276 $784,000
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $803,460 - $879,385
6,123
6,123 $830,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Avestar Capital, LLC Portfolio

Follow Avestar Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avestar Capital, LLC with notifications on news.